Cargando…

Nephrogenic systemic fibrosis: A frivolous entity

Gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging are vital in providing enhanced quality images, essential for diagnosis and treatment. Nephrogenic systemic fibrosis (NSF) with GBCAs has been a deterrent for the physician and has led to avoidance of these agents in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhargava, Vinant, Singh, Kulwant, Meena, Priti, Sanyal, Rupan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176868/ https://www.ncbi.nlm.nih.gov/pubmed/34136369 http://dx.doi.org/10.5527/wjn.v10.i3.29

Ejemplares similares

Frivolity's Labours
Publicado: (1890)

Hyperkalemia Unveiled: A Case of Barakat Syndrome
por: Singh, Kulwant, et al.
Publicado: (2020)

Nephrogenic systemic fibrosis
por: Braverman, Irwin M, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis
por: Madke, Bhushan, et al.
Publicado: (2011)

Nephrogenic systemic fibrosis
por: Koratala, Abhilash, et al.
Publicado: (2017)

Understanding Nephrogenic Systemic Fibrosis
por: Chopra, Tushar, et al.
Publicado: (2012)

Anemia in cirrhosis: An underestimated entity
por: Manrai, Manish, et al.
Publicado: (2022)

NEPHROGENIC SYSTEMIC FIBROSIS: TIME FOR THE REQUIEM?
por: Panda, Saumya
Publicado: (2011)

NEPHROGENIC SYSTEMIC FIBROSIS: CURRENT CONCEPTS
por: Basak, Prasanta, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis: Mini-Review
por: Mundim, Juliano Sacramento, et al.
Publicado: (2009)

NEPHROGENIC SYSTEMIC FIBROSIS: A BRIEF REVIEW
por: Waikhom, Rajesh, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis Risk and Liver Disease
por: Hanna, Robert F., et al.
Publicado: (2014)

Nephrogenic systemic fibrosis (NSF): the role of tamoxifen
por: Davison, Rachel, et al.
Publicado: (2010)

COVID-19 and the kidney: A matter of concern
por: Meena, Priti, et al.
Publicado: (2020)

Fungal arthritis: A challenging clinical entity
por: Mishra, Anjali, et al.
Publicado: (2023)

A moderate response to plasmapheresis in nephrogenic systemic fibrosis
por: Ustuner, Pelin, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
por: Elmholdt, Tina R., et al.
Publicado: (2013)

Catatonia as a putative nosological entity: A historical sketch
por: Gazdag, Gábor, et al.
Publicado: (2017)

Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
por: Mendichovszky, Iosif A., et al.
Publicado: (2007)

Transcriptional regulation of metastatic [Id]entity by KLF17
por: Iwanicki, Marcin P, et al.
Publicado: (2009)

10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016
por: Endrikat, Jan, et al.
Publicado: (2018)

Correction: Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
Publicado: (2014)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

NEPHROGENIC SYSTEMIC FIBROSIS: REVIEW OF 408 BIOPSY-CONFIRMED CASES
por: Zou, Zhitong, et al.
Publicado: (2011)

Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
por: Reiter, Theresa, et al.
Publicado: (2012)

Social Media and Organ Donation: Pros and Cons
por: Meena, Priti, et al.
Publicado: (2023)

Bilateral Acute Renal Infarction Secondary to Methylene Tetrahydrofolate Reductase A1298C and PAI-1 Mutation
por: Bhalla, Anil K., et al.
Publicado: (2020)

Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting
por: Beltrami, Matteo, et al.
Publicado: (2021)

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
por: Bennett, Charles L., et al.
Publicado: (2012)

Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis
por: Zhang, Ranran, et al.
Publicado: (2017)

Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation
por: Fuah, Kar Wah, et al.
Publicado: (2017)

Prevalence, risk, and outcomes of venous thromboembolic events in kidney transplant recipients: a nested case-control study
por: Bhargava, Vinant, et al.
Publicado: (2023)

Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis: Two distinct clinical and immunological entities?
por: Plavsic, Ivana, et al.
Publicado: (2018)

Absence of human herpes virus-8 (HHV8) in nephrogenic systemic fibrosis
por: O'Donnell, Patrick J, et al.
Publicado: (2008)

The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
por: Crowley, Anna Lisa, et al.
Publicado: (2012)

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
por: Elmholdt, Tina Rask, et al.
Publicado: (2010)

Prevalence and imaging features of nephrogenic systemic fibrosis at two large medical centers
por: Prince, Martin R, et al.
Publicado: (2009)

Adiponectin as a novel biomarker for liver fibrosis
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2018)

Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis
por: Bose, Chhanda, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_setldj4ihp0q4hrltje2509hf4